Rhythm Pharmaceuticals, Inc. RYTM Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s operating lease liabilities (current)?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported operating lease liabilities (current) of $676K in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s operating lease liabilities (current) changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s operating lease liabilities (current) increased by 201.8% year-over-year, from $224K to $676K.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s operating lease liabilities (current) has grown at a 4.0% compound annual growth rate (CAGR), from $535K to $650K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.